Xcout Intel
Nostopharma, LLC competitors & alternatives
The 12 closest competitors and alternatives to Nostopharma, LLC among biotechnology companies — ranked by similarity to what Nostopharma, LLC actually does, not by market-cap band.
Subscribe to see Nostopharma, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Nostopharma, LLC
Nostopharma is a women-owned biopharmaceutical company that develops novel precision delivery therapies and molecular interventions for patients with bone and connective tissue disorders. The company focuses on repurposing existing Hedgehog pathway inhibitors to prevent the onset of symptoms, slow disease progression, and treat conditions such as heterotopic ossification.
Nostopharma, LLC at a glance
Nostopharma, LLC is a biotechnology company headquartered in United States. It has raised at least $500,000 across the 2 funding rounds on record. Its most recent funding round raised $250,000 in September 2024. Xcout tracks 3 named people at Nostopharma, LLC, including Ekaterina Vert-Wong (Chief Executive Officer).
Nostopharma, LLC leadership
- Ekaterina Vert-WongChief Executive Officer
- Ekaterina Vert-WongExecutive Officer
- Jelena Gvozdenovic-JeremicExecutive Officer
Nostopharma, LLC funding rounds
At least $500,000 raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $250,000 | — | |
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Nostopharma, LLC competitors
Ranked by semantic similarity — how close each company is to Nostopharma, LLC by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Similar biotechnology company
Certa Therapeutics is a private biotechnology company headquartered in Melbourne, Australia, focused on developing innovative precision therapies for the treatment of fibrotic diseases.
Similar biotechnology company
Edgewise Therapeutics, Inc. is a biopharmaceutical firm dedicated to developing small-molecule treatments for a range of musculoskeletal disorders. Its leading investigational drug, EDG-5506, is an orally administered compound specifically engineered to tackle the fundamental genetic causes of dystrophinopathies, including Duchenne and Becker muscular dystrophy. This candidate has successfully concluded its Phase 1 clinical trial. Beyond EDG-5506, Edgewise maintains a pipeline of precision medicine candidates designed to modulate key muscle proteins, thereby addressing various genetically defined muscle conditions. Established in 2017, the company is headquartered in Boulder, Colorado.
Similar biotechnology company
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Similar biotechnology company
Rinascera Therapeutics, Inc. is a clinical-stage biotechnology company located in Boston, Massachusetts, dedicated to transforming the treatment of rare genetic skin diseases.
Biotech
Blueprint Medicines Corporation is a global precision therapy company that invents life-changing medicines, operating as a Sanofi company.
Biotech
Valerio Therapeutics is a biotechnology company that develops precision-guided therapeutics for complex and underserved diseases. It utilizes a proprietary V-Body conjugate platform, based on synthetic single-domain antibody libraries, to enable targeted drug delivery and deep tissue penetration.
Similar biotechnology company
Myosana Therapeutics, Inc. is a biotechnology research company based in Seattle, Washington, pioneering non-viral gene therapy treatments for muscle diseases.
Biotech
Mirador Therapeutics, Inc. is a clinical-stage precision medicine company headquartered in San Diego, California, focused on developing first- and best-in-class next-generation therapeutics.
Biotech
NanoVation Therapeutics is a platform developer headquartered in Vancouver, British Columbia, that partners with leading pharmaceutical and biotech companies to enable genetic medicines.
Healthcare Services
dNovo is a Silicon Valley-based startup focused on solving the aging problem by developing a potential cure for hair loss through direct reprogramming technology to generate personalized hair stem cells. The company aims to transform regenerative medicine by creating new stem cells from sources like skin and blood.
Healthtech
GATC Health Corp. is a biotechnology company that uses artificial intelligence, genomics, and toxicology data to discover and develop therapeutics and predict drug safety. Its work is aimed at pharmaceutical and biotechnology partners as well as patients needing treatments for serious diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Nostopharma, LLC and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Nostopharma, LLCand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →